354 related articles for article (PubMed ID: 26181025)
1. Evaluation of Urine Aquaporin-1 and Perilipin-2 Concentrations as Biomarkers to Screen for Renal Cell Carcinoma: A Prospective Cohort Study.
Morrissey JJ; Mellnick VM; Luo J; Siegel MJ; Figenshau RS; Bhayani S; Kharasch ED
JAMA Oncol; 2015 May; 1(2):204-12. PubMed ID: 26181025
[TBL] [Abstract][Full Text] [Related]
2. Urine aquaporin 1 and perilipin 2 differentiate renal carcinomas from other imaged renal masses and bladder and prostate cancer.
Morrissey JJ; Mobley J; Figenshau RS; Vetter J; Bhayani S; Kharasch ED
Mayo Clin Proc; 2015 Jan; 90(1):35-42. PubMed ID: 25572193
[TBL] [Abstract][Full Text] [Related]
3. Urinary concentrations of aquaporin-1 and perilipin-2 in patients with renal cell carcinoma correlate with tumor size and stage but not grade.
Morrissey JJ; Mobley J; Song J; Vetter J; Luo J; Bhayani S; Figenshau RS; Kharasch ED
Urology; 2014 Jan; 83(1):256.e9-14. PubMed ID: 24239027
[TBL] [Abstract][Full Text] [Related]
4. The specificity of urinary aquaporin 1 and perilipin 2 to screen for renal cell carcinoma.
Morrissey JJ; Kharasch ED
J Urol; 2013 May; 189(5):1913-20. PubMed ID: 23154208
[TBL] [Abstract][Full Text] [Related]
5. Urinary biomarkers for the early diagnosis of kidney cancer.
Morrissey JJ; London AN; Luo J; Kharasch ED
Mayo Clin Proc; 2010 May; 85(5):413-21. PubMed ID: 20375178
[TBL] [Abstract][Full Text] [Related]
6. Urinary aquaporin 1 and perilipin 2: Can these novel markers accurately characterize small renal masses and help guide patient management?
Song JB; Morrissey JJ; Mobley JM; Figenshau KG; Vetter JM; Bhayani SB; Kharasch ED; Figenshau RS
Int J Urol; 2019 Feb; 26(2):260-265. PubMed ID: 30467901
[TBL] [Abstract][Full Text] [Related]
7. Aquaporin-1 protein levels elevated in fresh urine of renal cell carcinoma patients: potential use for screening and classification of incidental renal lesions.
Sreedharan S; Petros JA; Master VA; Ogan K; Pattaras JG; Roberts DL; Lian F; Arnold RS
Dis Markers; 2014; 2014():135649. PubMed ID: 24803718
[TBL] [Abstract][Full Text] [Related]
8. Urinary KIM-1 and AQP-1 in patients with clear renal cell carcinoma: Potential noninvasive biomarkers.
Mijugković M; Stanojević I; Milović N; Cerović S; Petrović D; Jovanović D; Aleksić P; Kovacević B; Andjelić T; Terzic B; Djukić M; Vojvodić D
Vojnosanit Pregl; 2016 Mar; 73(3):266-72. PubMed ID: 27295912
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-15a expression measured in urine samples as a potential biomarker of renal cell carcinoma.
Mytsyk Y; Dosenko V; Borys Y; Kucher A; Gazdikova K; Busselberg D; Caprnda M; Kruzliak P; Farooqi AA; Lubov M
Int Urol Nephrol; 2018 May; 50(5):851-859. PubMed ID: 29549624
[TBL] [Abstract][Full Text] [Related]
10. Bioplasmonic paper-based assay for perilipin-2 non-invasively detects renal cancer.
Hu R; Gupta R; Wang Z; Wang C; Sun H; Singamaneni S; Kharasch ED; Morrissey JJ
Kidney Int; 2019 Dec; 96(6):1417-1421. PubMed ID: 31668633
[TBL] [Abstract][Full Text] [Related]
11. Expression of aquaporin 1 in primary renal tumors: a prognostic indicator for clear-cell renal cell carcinoma.
Huang Y; Murakami T; Sano F; Kondo K; Nakaigawa N; Kishida T; Kubota Y; Nagashima Y; Yao M
Eur Urol; 2009 Oct; 56(4):690-8. PubMed ID: 18930582
[TBL] [Abstract][Full Text] [Related]
12. Identification of Prognostic Biomarkers in the Urinary Peptidome of the Small Renal Mass.
Di Meo A; Batruch I; Brown MD; Yang C; Finelli A; Jewett MAS; Diamandis EP; Yousef GM
Am J Pathol; 2019 Dec; 189(12):2366-2376. PubMed ID: 31761032
[TBL] [Abstract][Full Text] [Related]
13. Human kidney injury molecule-1 is a tissue and urinary tumor marker of renal cell carcinoma.
Han WK; Alinani A; Wu CL; Michaelson D; Loda M; McGovern FJ; Thadhani R; Bonventre JV
J Am Soc Nephrol; 2005 Apr; 16(4):1126-34. PubMed ID: 15744000
[TBL] [Abstract][Full Text] [Related]
14. Screening for kidney cancer: is there a role for aquaporin-1 and adipophilin?
Grebe SK; Erickson LA
Mayo Clin Proc; 2010 May; 85(5):410-2. PubMed ID: 20435833
[No Abstract] [Full Text] [Related]
15. Searching for prognostic biomarkers for small renal masses in the urinary proteome.
Di Meo A; Batruch I; Brown MD; Yang C; Finelli A; Jewett MA; Diamandis EP; Yousef GM
Int J Cancer; 2020 Apr; 146(8):2315-2325. PubMed ID: 31465112
[TBL] [Abstract][Full Text] [Related]
16. Plasma Glycosaminoglycans as Diagnostic and Prognostic Biomarkers in Surgically Treated Renal Cell Carcinoma.
Gatto F; Blum KA; Hosseini SS; Ghanaat M; Kashan M; Maccari F; Galeotti F; Hsieh JJ; Volpi N; Hakimi AA; Nielsen J
Eur Urol Oncol; 2018 Oct; 1(5):364-377. PubMed ID: 31158075
[TBL] [Abstract][Full Text] [Related]
17. Adipophilin as prognostic biomarker in clear cell renal cell carcinoma.
Tolkach Y; Lüders C; Meller S; Jung K; Stephan C; Kristiansen G
Oncotarget; 2017 Apr; 8(17):28672-28682. PubMed ID: 28404922
[TBL] [Abstract][Full Text] [Related]
18. Urinary Biomarkers for the Detection and Management of Localized Renal Cell Carcinoma.
Rini BI; Campbell SC
JAMA Oncol; 2015 May; 1(2):212-3. PubMed ID: 26181026
[No Abstract] [Full Text] [Related]
19. Iodine quantification to distinguish clear cell from papillary renal cell carcinoma at dual-energy multidetector CT: a multireader diagnostic performance study.
Mileto A; Marin D; Alfaro-Cordoba M; Ramirez-Giraldo JC; Eusemann CD; Scribano E; Blandino A; Mazziotti S; Ascenti G
Radiology; 2014 Dec; 273(3):813-20. PubMed ID: 25162309
[TBL] [Abstract][Full Text] [Related]
20. Urine kidney injury molecule-1: a potential non-invasive biomarker for patients with renal cell carcinoma.
Zhang PL; Mashni JW; Sabbisetti VS; Schworer CM; Wilson GD; Wolforth SC; Kernen KM; Seifman BD; Amin MB; Geddes TJ; Lin F; Bonventre JV; Hafron JM
Int Urol Nephrol; 2014 Feb; 46(2):379-88. PubMed ID: 23979814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
